As I said in another thread, Motley Fool crowd moving in on the confirmation of a buy recommendation in relation to a discussion of PFR.That said, I think it will come off when is goes Ex Div.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
